Evidence map›Paper›PMID 39161137›Full record

ReviewCurrent pharmaceutical biotechnology2025

Uterine Biosynthesis through Tissue Engineering: An Overview of Current Methods and Status.

Krithika Sanjeev, Megaswana Guruprasad, Rachna Vikram, Snigdha Priyadarshini, Adhish Mazumder, Manjubala Inderchand

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Krithika SanjeevSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Megaswana GuruprasadSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Rachna VikramSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Snigdha PriyadarshiniSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Adhish MazumderSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Manjubala InderchandSchool of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last few decades, the rates of infertility among women have been on the rise, usually due to complications with the uterus and related tissue. A wide variety of reasons can cause uterine factor infertility and can be congenital or a result of disease. Uterine transplantation is currently used as a means to enable women with fertility issues to have a natural birth. However, multiple risk factors are involved in uterine transplantation that threaten the lives of the growing fetus and the mother, as a result of which the procedure is not prominently practiced. Uterine tissue engineering provides a potential solution to infertility through the regeneration of replacement of damaged tissue, thus allowing healing and restoration of reproductive capacity. It involves the use of stem cells from the patient incorporated within biocompatible scaffolds to regenerate the entire tissue. This manuscript discusses the need for uterine tissue engineering, giving an overview of the biological and organic material involved in the process. There are numerous existing animal models in which this procedure has been actualized, and the observations from them have been compiled here. These models are used to develop a further understanding of the integration of engineered tissues and the scope of tissue engineering as a treatment for uterine disorders. Additionally, this paper examines the scope and limitations of the procedure.

Indexed as

Tissue EngineeringUterusAnimalsFemaleHumansInfertility, FemaleTissue Scaffoldsanimal modelsbiosynthesis.stem cellstissue scaffoldsUterine diseasesuterine tissue engineering

Identifiers

PMID39161137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.